GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » EV-to-Revenue

Dr Lalchandani Labs (BOM:541299) EV-to-Revenue : 2.44 (As of May. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Dr Lalchandani Labs's enterprise value is ₹133.72 Mil. Dr Lalchandani Labs's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was ₹54.82 Mil. Therefore, Dr Lalchandani Labs's EV-to-Revenue for today is 2.44.

The historical rank and industry rank for Dr Lalchandani Labs's EV-to-Revenue or its related term are showing as below:

BOM:541299' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.46   Med: 1.29   Max: 5.01
Current: 2.44

During the past 11 years, the highest EV-to-Revenue of Dr Lalchandani Labs was 5.01. The lowest was 0.46. And the median was 1.29.

BOM:541299's EV-to-Revenue is ranked better than
59.19% of 223 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.23 vs BOM:541299: 2.44

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), Dr Lalchandani Labs's stock price is ₹21.89. Dr Lalchandani Labs's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was ₹12.58. Therefore, Dr Lalchandani Labs's PS Ratio for today is 1.74.


Dr Lalchandani Labs EV-to-Revenue Historical Data

The historical data trend for Dr Lalchandani Labs's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Lalchandani Labs EV-to-Revenue Chart

Dr Lalchandani Labs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.39 0.49 0.73 1.41 3.10

Dr Lalchandani Labs Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.41 - 3.10 -

Competitive Comparison of Dr Lalchandani Labs's EV-to-Revenue

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Lalchandani Labs's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's EV-to-Revenue falls into.



Dr Lalchandani Labs EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Dr Lalchandani Labs's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=133.717/54.824
=2.44

Dr Lalchandani Labs's current Enterprise Value is ₹133.72 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dr Lalchandani Labs's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was ₹54.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Lalchandani Labs  (BOM:541299) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Dr Lalchandani Labs's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=21.89/12.575
=1.74

Dr Lalchandani Labs's share price for today is ₹21.89.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was ₹12.58.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Lalchandani Labs EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Lalchandani Labs (BOM:541299) Business Description

Traded in Other Exchanges
N/A
Address
Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048
Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs (BOM:541299) Headlines

No Headlines